Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ambu A/S Unsponsored ADR (AMBBY : OTC)

• Company Description    Ambu A/S develops, produces, and sells medical devices to hospitals, clinics and rescue services. It provides anaesthesia, and patient monitoring and diagnostics products. Ambu A/S is based in Ballerup, Denmark. Number of Employees: 5,384

• Price / Volume Information    Yesterday's Closing Price: $11.00 Daily Weekly Monthly 20 Day Moving Average: 209 shares Shares Outstanding: 234.97 (millions) Market Capitalization: $2,584.71 (millions) Beta: 0.93 52 Week High: $16.78 52 Week Low: $8.55 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.29% 1.18% 12 Week 12.36% 7.64% Year To Date -16.67% -26.37%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BALTORPBAKKEN 13 - BALLERUP,G7 DK-2750 DNK ph: 45-7225-2000 fax: - anhj@ambu.com http://www.ambu.com

• General Corporate Information    Officers Britt Meelby Jensen - Chief Executive Officer Jorgen Jensen - Chairman Scott Heinzelman - President Graziela Malucelli - Chief Operations Officer Henrik Skak Bender - Chief Financial Officer Peer Information Ambu A/S Unsponsored ADR (MGLHQ) Ambu A/S Unsponsored ADR (AMBBY) Ambu A/S Unsponsored ADR (HMA.) Ambu A/S Unsponsored ADR (CPMIQ) Ambu A/S Unsponsored ADR (FPAMQ) Ambu A/S Unsponsored ADR (PSYS2) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-HOSPITALS Sector: Medical CUSIP: 02337W109 SIC: 6770 Fiscal Year Fiscal Year End: September Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 234.97 Most Recent Split Date: (:1) Beta: 0.93 Market Capitalization: $2,584.71 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.31% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.03 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.11 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: 0.06 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 36.67 PEG Ratio: - Price Ratios Price/Book: 2.71 Price/Cash Flow: 17.79 Price / Sales: 2.65 EPS Growth vs. Year Ago Period: 28.57% vs. Previous Quarter: 28.57% Sales Growth vs. Year Ago Period: 11.33% vs. Previous Quarter: 3.54% ROE 06/30/26 - 8.56 03/31/26 - 8.03 12/31/25 - 9.15 ROA 06/30/26 - 6.81 03/31/26 - 6.39 12/31/25 - 7.27 Current Ratio 06/30/26 - - 03/31/26 - 2.92 12/31/25 - 2.86 Quick Ratio 06/30/26 - - 03/31/26 - 1.73 12/31/25 - 1.67 Operating Margin 06/30/26 - 8.18 03/31/26 - 7.81 12/31/25 - 8.86 Net Margin 06/30/26 - 8.18 03/31/26 - 7.81 12/31/25 - 8.86 Pre-Tax Margin 06/30/26 - - 03/31/26 - 10.24 12/31/25 - 11.06 Book Value 06/30/26 - - 03/31/26 - 4.07 12/31/25 - 4.00 Inventory Turnover 06/30/26 - - 03/31/26 - 1.99 12/31/25 - 1.99 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.08 12/31/25 - 0.08 Debt-to-Capital 06/30/26 - - 03/31/26 - 7.10 12/31/25 - 7.27

Powered by Zacks Investment Research ©